(Q41512455)

English

Comparison of gastric cancer survival between Caucasian and Asian patients treated in the United States: results from the Surveillance Epidemiology and End Results (SEER) database

scientific article published on 29 January 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 October 2017

Comparison of gastric cancer survival between Caucasian and Asian patients treated in the United States: results from the Surveillance Epidemiology and End Results (SEER) database (English)

1 reference

Europe PubMed Central

1 October 2017

author name string

Jiping Wang

1

1 reference

Europe PubMed Central

1 October 2017

Yihong Sun

2

1 reference

Europe PubMed Central

1 October 2017

Monica M Bertagnolli

3

1 reference

Europe PubMed Central

1 October 2017

publication date

29 January 2015

1 reference

Europe PubMed Central

1 October 2017

Annals of Surgical Oncology

1 reference

Europe PubMed Central

1 October 2017

22

1 reference

Europe PubMed Central

1 October 2017

9

1 reference

Europe PubMed Central

1 October 2017

2965-2971

1 reference

Europe PubMed Central

1 October 2017

https://scigraph.springernature.com/pub.10.1245/s10434-015-4388-4

0 references

Cancer incidence trends among Asian American populations in the United States, 1990-2008

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4388-4

21 January 2018

Gastric carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4388-4

21 January 2018

Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4388-4

21 January 2018

The difference in gastric cancer between Japan, USA and Europe: what are the facts? what are the suggestions?

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4388-4

21 January 2018

Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4388-4

21 January 2018

Long-term survivors of gastric cancer: a California population-based study

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4388-4

21 January 2018

Is the prognosis for Japanese and German patients with gastric cancer really different?

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4388-4

21 January 2018

Ethnic survival differences after gastrectomy for gastric cancer are better explained by factors specific for disease location and individual patient comorbidity

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4388-4

21 January 2018

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4388-4

21 January 2018

The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Results from the National Cancer Data Base

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4388-4

21 January 2018

Helicobacter Pylori associated global gastric cancer burden.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4388-4

21 January 2018

Comparative genomic analysis of East Asian and non-Asian Helicobacter pylori strains identifies rapidly evolving genes.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4388-4

21 January 2018

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4388-4

21 January 2018

Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4388-4

21 January 2018

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4388-4

21 January 2018

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4388-4

21 January 2018

Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4388-4

21 January 2018

Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4388-4

21 January 2018

Comparison of disease-specific survival in the United States and Korea after resection for early-stage node-negative gastric carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-4388-4

21 January 2018

Identifiers

10.1245/S10434-015-4388-4

1 reference

Europe PubMed Central

1 October 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

1 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41512455&oldid=1922555151"